LifeMD annual ebitda
2012
2013
2014
2015
2021
2022
2023
2024
2025
LifeMD EBITDA Growth & History (LFMD)
LifeMD's calculated EBITDA was −$6.7M for fiscal 2025.
View full LifeMD company overviewLifeMD annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$6.7M | $13.2M | — |
| 2024 | 2024-12-31 | −$19.9M | −$6.6M | — |
| 2023 | 2023-12-31 | −$13.3M | $29.0M | — |
| 2022 | 2022-12-31 | −$42.4M | $11.6M | — |
| 2021 | 2021-12-31 | −$53.9M | — | — |
| 2015 | 2015-12-31 | −$218,469 | $255,435 | — |
| 2014 | 2014-12-31 | −$473,904 | $15,530 | — |
| 2013 | 2013-12-31 | −$489,434 | −$6,383 | — |
| 2012 | 2012-12-31 | −$483,051 | — | — |
LifeMD quarterly ebitda
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q3.18
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q1.24
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$6.8M | −$4.7M | — |
| Q1 2026 | 2026-03-31 | −$8.6M | −$7.6M | — |
| Q4 2025 | 2025-12-31 | −$2.1M | $2.4M | — |
| Q3 2025 | 2025-09-30 | −$1.4M | $2.2M | — |
| Q2 2025 | 2025-06-30 | −$2.1M | $3.8M | — |
| Q1 2025 | 2025-03-31 | −$1.0M | $4.8M | — |
| Q4 2024 | 2024-12-31 | −$4.5M | −$2.6M | — |
| Q2 2024 | 2024-09-30 | −$3.6M | $674,587 | — |
| Q1 2024 · Jun 30 | 2024-06-30 | −$6.0M | −$1.4M | — |
| Q1 2024 · Mar 31 | 2024-03-31 | −$5.9M | −$3.3M | — |
| Q4 2023 | 2023-12-31 | −$1.9M | $8.2M | — |
| Q3 2023 | 2023-09-30 | −$4.3M | $2.4M | — |
| Q2 2023 | 2023-06-30 | −$4.6M | $8.0M | — |
| Q1 2023 | 2023-03-31 | −$2.6M | $10.4M | — |
| Q4 2022 | 2022-12-31 | −$10.1M | — | — |
| Q3 2022 | 2022-09-30 | −$6.7M | — | — |
| Q2 2022 | 2022-06-30 | −$12.6M | — | — |
| Q1 2022 | 2022-03-31 | −$13.0M | — | — |
| Q3 2018 | 2018-09-30 | −$354,217 | — | — |
| Q4 2015 | 2015-12-31 | −$270,822 | −$140,147 | — |
| Q3 2015 | 2015-09-30 | $33,202 | $151,904 | — |
| Q2 2015 | 2015-06-30 | −$2,926 | $58,207 | — |
| Q1 2015 | 2015-03-31 | $22,077 | $185,471 | — |
| Q4 2014 | 2014-12-31 | −$130,675 | $141,883 | — |
| Q3 2014 | 2014-09-30 | −$118,702 | $35,720 | — |
| Q2 2014 | 2014-06-30 | −$61,133 | −$55,222 | — |
| Q1 2014 | 2014-03-31 | −$163,394 | −$106,851 | — |
| Q4 2013 | 2013-12-31 | −$272,558 | −$162,229 | — |
| Q3 2013 | 2013-09-30 | −$154,422 | −$4,881 | — |
| Q2 2013 | 2013-06-30 | −$5,911 | $195,544 | — |
| Q1 2013 | 2013-03-31 | −$56,543 | −$34,817 | — |
| Q4 2012 | 2012-12-31 | −$110,329 | — | — |
| Q3 2012 | 2012-09-30 | −$149,541 | — | — |
| Q2 2012 | 2012-06-30 | −$201,455 | — | — |
| Q1 2012 | 2012-03-31 | −$21,726 | — | — |
LifeMD ebitda trends
Between the periods ended 2012-12-31 and 2025-12-31, LifeMD's ebitda decreased from −$483,051 to −$6.7M, a change of −$6.2M. The latest reported quarter, Q2 2026, shows −$6.8M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review LifeMD source filings ↗